Point72 Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Buy |
+391,280
| New | +$2.54M | 0.01% | 805 |
|
|
2024
Q3 | – | Sell |
-470,247
| Closed | -$6.48M | – | 1326 |
|
|
2024
Q2 | $6.48M | Buy |
+470,247
| New | +$6.48M | 0.02% | 590 |
|
|
2024
Q1 | – | Sell |
-88,000
| Closed | -$1.28M | – | 1535 |
|
|
2023
Q4 | $1.28M | Sell |
88,000
-456,560
| -84% | -$6.67M | ﹤0.01% | 896 |
|
|
2023
Q3 | $6.68M | Buy |
544,560
+413,560
| +316% | +$5.07M | 0.02% | 650 |
|
|
2023
Q2 | $1.56M | Buy |
+131,000
| New | +$1.56M | ﹤0.01% | 825 |
|
|
2023
Q1 | – | Sell |
-461,631
| Closed | -$9.93M | – | 1744 |
|
|
2022
Q4 | $9.93M | Buy |
+461,631
| New | +$9.93M | 0.03% | 502 |
|